Health ministry to improve domestic R&D environment

Published: 2007-07-31 06:56:00

Updated: 2007-07-31 06:56:00

The Ministry of Health and Welfare unveiled the plan on July 26 to encourage the research and development (R&D) activities of domestic pharmaceutical firms after screening their R&D projects in advance, a move aimed at boosting the corporate R&D environment.

We will set up various policies for...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK